Both web-based and print-based decision aids appear to improve patient’s informed decision making about prostate cancer screening up to 13 months later, according to a new study by researchers at Georgetown University.

The new study also found that these decision aids do not appear to affect actual PSA screening rates.

Continue Reading

John Schieszer has the story in today’s Medical Minute.